[HTML][HTML] Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer
Z Wang, Y Xing, B Li, X Li, B Liu, Y Wang - Molecular biomedicine, 2022 - Springer
Lung cancer is the leading cause of cancer-related mortality worldwide. The discovery of
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer.
Z Wang, Y Xing, B Li, X Li, B Liu, Y Wang - Molecular Biomedicine, 2022 - europepmc.org
Lung cancer is the leading cause of cancer-related mortality worldwide. The discovery of
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer
Z Wang, Y Xing, B Li, X Li, B Liu… - Molecular …, 2022 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer-related mortality worldwide. The discovery of
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer
Z Wang, Y Xing, B Li, X Li, B Liu… - Molecular …, 2022 - search.proquest.com
Lung cancer is the leading cause of cancer-related mortality worldwide. The discovery of
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
[HTML][HTML] Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer
Z Wang, Y Xing, B Li, X Li, B Liu, Y Wang - Molecular Biomedicine, 2022 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer-related mortality worldwide. The discovery of
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
[引用][C] Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer
Z Wang, Y Xing, B Li, X Li, B Liu, Y Wang - 2022 - europepmc.org
Lung cancer is the leading cause of cancer-related mortality worldwide. The discovery of
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …
tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in …